Our team is attending the World ADC Event Series taking place in San Diego between Nov 4-7. Our CEO Ali Salanti will be accompanied by Tobias Gustavsson, Swati Choudhary, Robert Dagil and Thomas Clausen. We are looking forward to meeting old and new partners to discuss synergies around our lead ADC based on first-in-class antibodies against oncofetal CS and how to move these to clinical practice.